[{"id":131,"run_id":7,"as_of":"2026-08-10","ticker":"PFE","company":"Pfizer, Inc.","source":"ticker","conviction":49.1,"technical":50.1,"stage":"Mature Trend","gated":true,"n_gates":2,"gates":["50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.10 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":27.09,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":11.5,"Volatility behaviour":14.6,"Cross-asset confirmation":7.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1959190.0,"n_cfo_buys":0.0,"n_other_buys":2.0,"has_cfo_buy":false,"roles_buying":"2 Director","npr":0.8713748017409071,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-10T16:32:53.552662+00:00"},{"id":488,"run_id":19,"as_of":"2026-08-11","ticker":"PFE","company":"Pfizer","source":"scan","conviction":43.0,"technical":51.2,"stage":"Mature Trend","gated":true,"n_gates":2,"gates":["50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.08 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":26.61,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":11.5,"Volatility behaviour":14.8,"Cross-asset confirmation":7.7,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":2.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":null,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-11T03:29:59.217548+00:00"},{"id":1702,"run_id":29,"as_of":"2026-08-13","ticker":"PFE","company":"Pfizer","source":"scan","conviction":43.9,"technical":52.4,"stage":"Mature Trend","gated":true,"n_gates":2,"gates":["50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.09 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":26.31,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":11.5,"Volatility behaviour":15.4,"Cross-asset confirmation":8.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":2.0},"total_cfo_value":null,"total_other_value":null,"n_cfo_buys":null,"n_other_buys":null,"has_cfo_buy":false,"roles_buying":null,"npr":null,"cluster_insiders":1.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-13T00:18:50.531812+00:00"},{"id":2013,"run_id":48,"as_of":"2026-08-14","ticker":"PFE","company":"Pfizer, Inc.","source":"ticker","conviction":56.7,"technical":56.5,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.10 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":26.79,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":7.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-14T02:06:50.686944+00:00"},{"id":3369,"run_id":58,"as_of":"2026-08-17","ticker":"PFE","company":"Pfizer","source":"scan","conviction":56.7,"technical":56.5,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.10 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":26.83,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":7.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-17T19:19:32.921075+00:00"},{"id":3764,"run_id":65,"as_of":"2026-08-18","ticker":"PFE","company":"Pfizer","source":"scan","conviction":57.4,"technical":57.4,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.11 vs the 0.15 threshold (genuine chop)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":27.25,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":7.4,"Sponsorship / positioning":7.3,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-18T13:41:59.665918+00:00"},{"id":4436,"run_id":79,"as_of":"2026-08-19","ticker":"PFE","company":"Pfizer, Inc.","source":"ticker","conviction":60.3,"technical":61.0,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.31,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.9,"Volatility behaviour":15.7,"Cross-asset confirmation":9.2,"Sponsorship / positioning":8.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-19T18:43:39.466815+00:00"},{"id":4751,"run_id":146,"as_of":"2026-08-21","ticker":"PFE","company":"Pfizer","source":"scan","conviction":60.1,"technical":60.7,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.14 vs the 0.15 threshold (borderline, watch for resolution)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":27.79,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":8.7,"Sponsorship / positioning":8.7,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-21T12:50:47.832736+00:00"},{"id":5460,"run_id":242,"as_of":"2026-08-22","ticker":"PFE","company":"Pfizer Inc","source":"weekly","conviction":61.6,"technical":62.6,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.13 vs the 0.15 threshold (borderline, watch for resolution)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":28.07,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":9.6,"Sponsorship / positioning":9.3,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-22T14:49:55.536534+00:00"},{"id":5544,"run_id":262,"as_of":"2026-08-24","ticker":"PFE","company":"Pfizer","source":"scan","conviction":61.5,"technical":62.5,"stage":"Mature Trend","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.13 vs the 0.15 threshold (borderline, watch for resolution)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":27.97,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":15.7,"Cross-asset confirmation":8.7,"Sponsorship / positioning":10.1,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":true,"created_at":"2026-08-24T13:43:37.609921+00:00"},{"id":6189,"run_id":270,"as_of":"2026-08-25","ticker":"PFE","company":"Pfizer Inc","source":"weekly","conviction":63.2,"technical":64.6,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.57,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.7,"Volatility behaviour":15.7,"Cross-asset confirmation":9.4,"Sponsorship / positioning":10.9,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-25T16:34:31.919235+00:00"},{"id":7012,"run_id":311,"as_of":"2026-08-26","ticker":"PFE","company":"Pfizer, Inc.","source":"ticker","conviction":64.2,"technical":65.9,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.3,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":16.1,"Volatility behaviour":15.8,"Cross-asset confirmation":9.2,"Sponsorship / positioning":11.6,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-26T20:44:22.189017+00:00"},{"id":7751,"run_id":391,"as_of":"2026-08-27","ticker":"PFE","company":"Pfizer","source":"scan","conviction":64.0,"technical":65.6,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.02,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.8,"Volatility behaviour":16.0,"Cross-asset confirmation":8.4,"Sponsorship / positioning":12.3,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-27T20:17:55.852107+00:00"},{"id":8376,"run_id":412,"as_of":"2026-08-28","ticker":"PFE","company":"Pfizer","source":"scan","conviction":64.0,"technical":65.6,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.02,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":15.8,"Volatility behaviour":16.0,"Cross-asset confirmation":8.4,"Sponsorship / positioning":12.3,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-29T11:54:20.316176+00:00"},{"id":8980,"run_id":413,"as_of":"2026-08-30","ticker":"PFE","company":"Pfizer Inc","source":"weekly","conviction":67.6,"technical":70.1,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":27.96,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":16.0,"Volatility behaviour":20.0,"Cross-asset confirmation":7.1,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-30T01:15:14.903614+00:00"},{"id":9071,"run_id":416,"as_of":"2026-08-31","ticker":"PFE","company":"Pfizer","source":"scan","conviction":65.8,"technical":67.9,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.46,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":16.1,"Volatility behaviour":16.0,"Cross-asset confirmation":8.5,"Sponsorship / positioning":13.7,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-31T21:22:03.535773+00:00"},{"id":9667,"run_id":417,"as_of":"2026-09-01","ticker":"PFE","company":"Pfizer Inc","source":"weekly","conviction":66.7,"technical":69.0,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":28.55,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.9,"Volatility behaviour":16.0,"Cross-asset confirmation":9.3,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-01T21:37:53.063049+00:00"},{"id":9757,"run_id":419,"as_of":"2026-09-02","ticker":"PFE","company":"Pfizer","source":"scan","conviction":68.7,"technical":71.5,"stage":"Mature Trend","gated":false,"n_gates":0,"gates":[],"sizing_low":17500.0,"sizing_high":24500.0,"sizing_label":"Standard","close":29.02,"sector":"Health Care","etf":"XLV","pillars":{"Regime clarity":16.9,"Volatility behaviour":16.0,"Cross-asset confirmation":10.3,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":11.5},"total_cfo_value":0.0,"total_other_value":2960110.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Director","npr":0.9129751442029151,"cluster_insiders":3.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-02T21:23:53.374859+00:00"}]